TrivarX

TrivarX is an Australian health technology company focused on developing objective, AI-driven screening and diagnostic tools for mental health conditions. The company's flagship technology, MEB-001, leverages proprietary algorithms to analyze physiological biomarkers such as heart rate variability and sleep patterns to identify signatures of Major Depressive Disorder. By utilizing smartphone-based data collection, TrivarX aims to provide a scalable and non-invasive alternative to traditional subjective mental health assessments. The company is currently conducting clinical validation studies to support regulatory submissions and commercialization efforts in global markets. Formerly known as Advanced Human Imaging, TrivarX is listed on the Australian Securities Exchange and continues to expand its digital health portfolio.